Home > Cashflow Statement > INDOCO REMEDIES

INDOCO REMEDIES
Cash Flow from Financing Activities

    Back to Cashflow Statement
INDOCO REMEDIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results

INDOCO REMEDIES Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Financing Activities ₹241 Cr₹280 Cr₹23 Cr₹-44 Cr₹-30 Cr

What is the latest Cash Flow from Financing Activities ratio of INDOCO REMEDIES ?

The latest Cash Flow from Financing Activities ratio of INDOCO REMEDIES is ₹241 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Financing Activities
Mar2025₹241 Cr
Mar2024₹280 Cr
Mar2023₹23 Cr
Mar2022₹-44 Cr
Mar2021₹-30 Cr

How is Cash Flow from Financing Activities of INDOCO REMEDIES Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹241 Cr
-13.91
Mar2024 ₹280 Cr
1,129.76
Mar2023 ₹23 Cr
Positive
Mar2022 ₹-44 Cr
Negative
Mar2021 ₹-30 Cr -

Compare Cash Flow from Financing Activities of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹2,105.4 Cr -0.6% -10.8% -29.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹414,929.0 Cr 0.7% -4.2% -8.7% Stock Analytics
DIVIS LABORATORIES ₹169,644.0 Cr 0% -1% 4% Stock Analytics
TORRENT PHARMACEUTICALS ₹131,481.0 Cr 2.4% 4.5% 14.5% Stock Analytics
CIPLA ₹122,050.0 Cr 1.1% 0.2% -1.9% Stock Analytics
DR REDDYS LABORATORIES ₹104,784.0 Cr -1% -2% -9.7% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

-0.6%

-10.8%

-29.2%

SENSEX

0.9%

0.7%

9.6%


You may also like the below Video Courses